Heinz-Josef Schmoll

Heinz-Josef Schmoll is a senior European gastrointestinal oncologist who has contributed to defining adjuvant and palliative treatment standards in colorectal cancer through leadership of major cooperative clinical trials. He has studied molecular biomarkers including MSI status as predictors of adjuvant therapy benefit in colorectal cancer. His extensive clinical trial portfolio spans decades of advances in colorectal cancer treatment. He has been a leading voice in integrating biomarker-directed therapy approaches into European colorectal cancer treatment guidelines.